Gene expression profiling of the proliferative effect of periplocin on mouse cardiac microvascular endothelial cells

Chinese Journal of Integrative Medicine

Volumn 16, Issue 1, 2010, Pages 33-40

  Wang, Xiao Ying ^a   Gao, Xiu Mei ^a   Liu, Hong ^a   Zhang, Han ^a   Liu, Yang ^a   Jiang, Min ^a   Hu, Li Min ^a   Zhang, Bo Li ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cardiac microvascular endothelial cells; GTP binding; Periplocin; Proliferation; Protein serine threonine kinase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; CARDIAC AGENT; CELL PROTEIN; CHINESE DRUG; COMPLEMENTARY DNA; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; MESSENGER RNA; OUABAIN; PERIPLOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ASSAY; ENZYME RELEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART BLOOD VESSEL; MICROARRAY ANALYSIS; MICROVASCULATURE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANIMALS, NEWBORN; CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CORONARY VESSELS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICROVESSELS; MODELS, BIOLOGICAL; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OUABAIN; SAPONINS;

EID: 76649116895     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-010-0033-z     Document Type: Article

References (31)

1. China Pharmacopoeia Committee. Pharmacopeia of the People's Republic of China (2005 ed). Part 1. Beijing: Chemical Industry Press; 2005:181.
2. Egawa K, Kurihara Y, lto T, Matsumoto M, Nose K. Induction of p16INK4a transcription and of cellular senescence by clacinomycin-derivatives and cardiac glycosides. Biol Pharm Bull 2002;25:461-465.
3. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, et al. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci USA 2005;102:9631-9636.
4. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs 2007;7:173-189.
5. Umehara K, Sumii N, Satoh H, Miyase T, Kuroyanagi M, Ueno A. Studies on differentiation inducers. V. Steroid glycosides from periplocae radicis cortex. Chem Pharm Bull (Tokyo) 1995;43:1565-1568.
6. Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 2005;289:H1781-1793.
7. Li YH, Gao XM, Zhang BL, Xu Q, Liu H, Pan GX. Effect of the Chinese medicine Xiangjiapi on cardiac function of isolated hearts. J Liaoning Coll Tradit Chin Med (Chin) 2005;7:396-397.
8. Xie YS, Ren XL, Pan GX, Gao XM, Liu CX. The assessment of absorption of periplocin in situ via intestinal perfusion of rats by HPLC. Biomed Chromatogr 2008;22:196-201.
9. Trevisi L, Pighin I, Luciani S. Vascular endothelium as a target for endogenous ouabain: studies on the effect of ouabain on human endothelial cells. Cell Mol Biol (Noisy-legrand) 2006;52:64-70.
10. Ren YP, Huang RW, Lu ZR. Ouabain at pathological concentrations might induce damage in human vascular endothelial cells. Acta Pharmacol Sin 2006;27:165-172.
11. Qiu J, Gao HQ, Liang Y, Yu H, Zhou RH. Comparative proteomics analysis reveals role of heat shock protein 60 in digoxin-induced toxicity in human endothelial cells. Biochim Biophys Acta 2008;1784:1857-1864.
12. Winnicka K, Bielawski K, Bielawska A, Surazy ń ski A. Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells. Biol Pharm Bull 2008;31:1131-1140.
13. Nishida M, Carley WW, Gerritsen ME, Ellingsen O, Kelly RA, Smith TW. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol 1993;264(2 Pt 2):639-652.
14. Moccia F, Villa A, Tanzi F. Flow-activated Na(+) and K(+) current in cardiac microvascular endothelial cells. J Mol Cell Cardiol 2000;32:1589-1593.
15. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-534,536-537.
16. Sun H, Fang H, Chen T, Perkins R, Tong W. GOFFA: gene ontology for functional analysis-A FDA gene ontology tool for analysis of genomic and proteomic Data. BMC Bioinformatics 2006;7 Suppl 2:S23.
17. Rochat-Steiner V, Becker K, Micheau O, Schneider P, Burns K, Tschopp J. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J Exp Med 2000;192:1165-1174.
18. Inoue T, Hammaker D, Boyle DL, Firestein GS. Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J Immunol 2005;174:4301-4306.
19. Page C, Doubell AF. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem 1996;157:49-57.
20. Vallenius T, Mäketä TP. Clik1: a novel kinase targeted to actin stress fibers by the CLP-36 PDZ-LIM protein. J Cell Sci 2002;115(Pt 10):2067-2073.
21. Groth A, Lukas J, Nigg EA, Silljé HH, Wernstedt C, Bartek J, et al. Human Tousled like kinases are targeted by an ATM-and Chk1-dependent DNA damage checkpoint. EMBO J 2003;22:1676-1687.
22. DeVries-Seimon TA, Ohm AM, Humphries MJ, Reyland ME. Induction of apoptosis is driven by nuclear retention of protein kinase C delta. J Biol Chem 2007;282:22307-22314.
23. Brodie C, Steinhart R, Kazimirsky G, Rubinfeld H, Hyman T, Ayres JN, et al. PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol 2004;66:76-84.
24. Tong H, Rockman HA, Koch WJ, Steenbergen C, Murphy E. G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res 2004;94:1133-1141.
25. 2+/calmodulin kinase II. J Clin Invest 2003;111:617-625.
26. Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circ Res 1987;60:153-168.
27. Pittner J, Rhinehart K, Pallone TL. Ouabain modulation of endothelial calcium signaling in descending vasa recta. Am J Physiol Renal Physiol 2006;291:F761-769.
28. Ren YP, Lu ZR. Gene expression analysis of human vascular endothelial cells treated by ouabain in Pathological Concentration. South China J Cardiol (Chin) 2004;5:25-28.
29. Qiu J, Gao HQ, Zhou RH, Liang Y, Zhang XH, Wang XP, et al. Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull 2007;30:247-253.
30. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 2008;105:19579-19586.
31. Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, Shinbo T, et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 2003;301:598-603.